Neumora Therapeutics (NMRA) Insider Trading & Ownership $0.41 +0.01 (+3.54%) As of 10:52 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings Neumora Therapeutics (NASDAQ:NMRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.94%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.09M Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMRA Insider Buying and Selling by Quarter Neumora Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type 10/29/2025 - 10/29/2026 Transaction Date Transaction Date From Transaction Date To 1M3M6MYTD1Y2Y3Y More filters Fewer filters Done 0 Results Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/21/2026Daljit Singh AuroraInsiderSell20,553$1.59$32,679.27 8/21/2026Daljit Singh AuroraInsiderSell21,055$1.60$33,688.00 8/20/2026Daljit Singh AuroraInsiderSell67,741$1.51$102,288.91 8/20/2026Daljit Singh AuroraInsiderSell66,711$1.51$100,733.61 8/19/2026Daljit Singh AuroraInsiderSell31,000$1.65$51,150.00 8/19/2026Daljit Singh AuroraInsiderSell30,918$1.65$51,014.70 8/18/2026Daljit Singh AuroraInsiderSell34,162$1.58$53,975.96 8/18/2026Daljit Singh AuroraInsiderSell34,987$1.59$55,629.33 8/17/2026Daljit Singh AuroraInsiderSell91,690$1.50$137,535.00 8/17/2026Daljit Singh AuroraInsiderSell55,016$1.50$82,524.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/17/2026Daljit Singh AuroraInsiderSell6,165$3.56$21,947.40 2/17/2026Joshua PintoPresidentSell5,967$3.54$21,123.18 2/17/2026Michael Lee MilliganInsiderSell1,436$3.56$5,112.16 2/17/2026Paul L BernsInsiderSell9,819$3.51$34,464.69 11/11/2025Daljit Singh AuroraInsiderSell114,703$2.68$307,404.04 (Data available from 1/1/2013 forward) NMRA Insider Trading Activity - Frequently Asked Questions Who is on Neumora Therapeutics' Insider Roster? The list of insiders at Neumora Therapeutics includes Arch Venture Partners Xii, Llc, Daljit Singh Aurora, Joshua Pinto, Kristina Burow, Matthew K Fust, Michael Lee Milligan, Paul L Berns, and Robert A Lenz. Learn more on insiders at NMRA. What percentage of Neumora Therapeutics stock is owned by insiders? 26.94% of Neumora Therapeutics stock is owned by insiders. Learn more on NMRA's insider holdings. Which Neumora Therapeutics insiders have been buying company stock? The following insiders have purchased NMRA shares in the last 24 months: Arch Venture Partners Xii, Llc ($4,999,977.00), and Kristina Burow ($4,999,977.00). How much insider buying is happening at Neumora Therapeutics? Insiders have purchased a total of 3,831,400 NMRA shares in the last 24 months for a total of $9,999,954.00 bought. Which Neumora Therapeutics insiders have been selling company stock? The following insiders have sold NMRA shares in the last 24 months: Daljit Singh Aurora ($1,030,570.22), Joshua Pinto ($34,563.34), Michael Lee Milligan ($8,454.98), and Paul L Berns ($34,464.69). How much insider selling is happening at Neumora Therapeutics? Insiders have sold a total of 601,949 Neumora Therapeutics shares in the last 24 months for a total of $1,108,053.23 sold. Neumora Therapeutics Active InsidersJoshua PintoPresidentKristina BurowDirectorMatthew K FustDirectorMichael Lee Milligan (Age 53)InsiderPaul L BernsInsider More Insider Trading Tools from MarketBeat Related Companies Adherex Technologies Insider Trading Atea Pharmaceuticals Insider Trading Relmada Therapeutics Insider Trading Enanta Pharmaceuticals Insider Trading Canopy Growth Insider Trading Turn Therapeutics Insider Trading Glass House Brands Insider Trading Eyepoint Pharmaceuticals Insider Trading Palisade Bio Insider Trading Vanda Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure WinnerOff-Price, High-Yield: Why Ross Stores Is Defying the Retail SlumpIntel's $155 Price Target Raises a Bigger Question About Its Turnaround PotentialInsiders Are Selling These 5 AI Stocks—Should You Worry?Intercepting Growth: Karman Secures $218M Lockheed Martin Deal Insider trading data for NASDAQ:NMRA was last updated on 8/21/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported. From Our PartnersA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredElon Musk's Intel Deal Already Jumped 177 Percent This YearElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
